Gauthier M, Kale S, Ray A
Immunol Rev. 2025; 330(1):e70011.
PMID: 39991821
PMC: 11849004.
DOI: 10.1111/imr.70011.
Brightling C, Marone G, Aegerter H, Chanez P, Heffler E, Pavord I
Eur Respir Rev. 2024; 33(174.
PMID: 39694589
PMC: 11653196.
DOI: 10.1183/16000617.0221-2024.
Everard M, Priftis K, Koumbourlis A, Shields M
Front Pediatr. 2024; 12:1391290.
PMID: 38910961
PMC: 11190372.
DOI: 10.3389/fped.2024.1391290.
Cottin S, Doyen V, Pilette C
Front Med (Lausanne). 2023; 10:1129300.
PMID: 37035303
PMC: 10073432.
DOI: 10.3389/fmed.2023.1129300.
Pembrey L, Brooks C, Mpairwe H, Figueiredo C, Oviedo A, Chico M
Int J Epidemiol. 2022; 52(2):611-623.
PMID: 36040171
PMC: 10114118.
DOI: 10.1093/ije/dyac173.
Onward and Upward: Beyond Personalized Medicine to Proactive Medicine.
Bush A
Pediatr Allergy Immunol Pulmonol. 2022; 33(3):124-126.
PMID: 35922030
PMC: 9354030.
DOI: 10.1089/ped.2020.1246.
WAO-ARIA consensus on chronic cough - Part III: Management strategies in primary and cough-specialty care. .
Rouadi P, Idriss S, Bousquet J, Laidlaw T, Azar C, Al-Ahmad M
World Allergy Organ J. 2022; 15(5):100649.
PMID: 35600836
PMC: 9117692.
DOI: 10.1016/j.waojou.2022.100649.
ERS International Virtual Congress 2021: Highlights from the Turkish Thoracic Society Early Career Members.
Yumrukuz Senel M, Karadogan D, Vardaloglu I, Develi E, Celik S, Hizal M
Turk Thorac J. 2022; 23(2):173-184.
PMID: 35404250
PMC: 9450223.
DOI: 10.5152/TurkThoracJ.2022.21289.
Pathophysiological and Clinical Aspects of Chronic Rhinosinusitis: Current Concepts.
Vlaminck S, Acke F, Scadding G, Lambrecht B, Gevaert P
Front Allergy. 2022; 2:741788.
PMID: 35387015
PMC: 8974859.
DOI: 10.3389/falgy.2021.741788.
Challenging the paradigm.
Everard M
Breathe (Sheff). 2022; 18(1):210148.
PMID: 35284017
PMC: 8908862.
DOI: 10.1183/20734735.0148-2021.
Eosinophils and eosinophilic immune dysfunction in health and disease.
Jackson D, Akuthota P, Roufosse F
Eur Respir Rev. 2022; 31(163).
PMID: 35082127
PMC: 9489126.
DOI: 10.1183/16000617.0150-2021.
Challenging the paradigm: moving from umbrella labels to treatable traits in airway disease.
Bush A, Pavord I
Breathe (Sheff). 2022; 17(3):210053.
PMID: 35035544
PMC: 8753662.
DOI: 10.1183/20734735.0053-2021.
WAO-ARIA consensus on chronic cough - Part 1: Role of TRP channels in neurogenic inflammation of cough neuronal pathways.
Rouadi P, Idriss S, Bousquet J, Laidlaw T, Azar C, Sulaiman Al-Ahmad M
World Allergy Organ J. 2021; 14(12):100617.
PMID: 34934475
PMC: 8654622.
DOI: 10.1016/j.waojou.2021.100617.
Distribution of inflammatory phenotypes among patients with asthma in Jilin Province, China: a cross-sectional study.
Shi B, Li W, Dong H, Xu M, Hao Y, Gao P
BMC Pulm Med. 2021; 21(1):364.
PMID: 34772390
PMC: 8590234.
DOI: 10.1186/s12890-021-01722-0.
Latest Progresses in Allergic Diseases Biomarkers: Asthma and Atopic Dermatitis.
Puzzovio P, Levi-Schaffer F
Front Pharmacol. 2021; 12:747364.
PMID: 34658882
PMC: 8514744.
DOI: 10.3389/fphar.2021.747364.
Oral corticosteroids stewardship for asthma in adults and adolescents: A position paper from the Thoracic Society of Australia and New Zealand.
Blakey J, Chung L, McDonald V, Ruane L, Gornall J, Barton C
Respirology. 2021; 26(12):1112-1130.
PMID: 34587348
PMC: 9291960.
DOI: 10.1111/resp.14147.
Recent Insights into the Management of Inflammation in Asthma.
Rupani H, Fong W, Kyyaly A, Kurukulaaratchy R
J Inflamm Res. 2021; 14:4371-4397.
PMID: 34511973
PMC: 8421249.
DOI: 10.2147/JIR.S295038.
Precision Medicine for Paediatric Severe Asthma: Current Status and Future Direction.
Ramphul M, Lo D, Gaillard E
J Asthma Allergy. 2021; 14:525-538.
PMID: 34045872
PMC: 8144021.
DOI: 10.2147/JAA.S265657.
Determinants of response to inhaled extrafine triple therapy in asthma: analyses of TRIMARAN and TRIGGER.
Singh D, Virchow J, Canonica G, Vele A, Kots M, Georges G
Respir Res. 2020; 21(1):285.
PMID: 33121501
PMC: 7597025.
DOI: 10.1186/s12931-020-01558-y.
Treatment options in type-2 low asthma.
Hinks T, Levine S, Brusselle G
Eur Respir J. 2020; 57(1).
PMID: 32586877
PMC: 7116624.
DOI: 10.1183/13993003.00528-2020.